Filing Details
- Accession Number:
- 0001214659-22-000856
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-01-18 20:32:53
- Reporting Period:
- 2022-01-14
- Accepted Time:
- 2022-01-18 20:32:53
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1576263 | Mirati Therapeutics Inc. | MRTX | Pharmaceutical Preparations (2834) | 462693615 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1579824 | M Charles Baum | C/O Mirati Therapeutics Inc. 3545 Cray Court San Diego CA 92121 | President,Founder,Head Of R&D | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-01-14 | 25,543 | $0.00 | 126,713 | No | 4 | A | Direct | |
| Common Stock | Acquisiton | 2022-01-18 | 3,703 | $27.00 | 130,416 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-01-18 | 2,517 | $120.48 | 127,899 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (Right to Buy) | Acquisiton | 2022-01-14 | 42,325 | $0.00 | 42,325 | $124.31 |
| Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2022-01-18 | 3,703 | $0.00 | 3,703 | $27.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 42,325 | 2032-01-13 | No | 4 | A | Direct | |
| 178,052 | 2028-01-17 | No | 4 | M | Direct |
Footnotes
- Grant of Restricted Stock Units (RSUs). Shares will vest 25% annually on the anniversary of the grant date until fully vested.
- Represents shares sold by the Company to satisfy the tax withholding obligation associated with the vesting of a portion of the restricted stock units (RSUs) granted on January 15, 2021.
- The price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $120.19 to $120.49, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.
- 25% of the shares subject to the Option shall vest and become exercisable on the first anniversary of the date of grant, and 1/48th of the shares subject to the Option shall vest each month thereafter until fully vested.
Billionaire Hedge Funds
